Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
riboceine
- Development stage
- Preclinical
- Lead developer
- Max International
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Riboceine is a synthetic compound consisting of D-ribose and L-cysteine, developed to enhance endogenous glutathione synthesis and support cellular antioxidant defenses. The patented structure enables effective delivery of cysteine into cells, which is the rate-limiting precursor for glutathione biosynthesis. D-ribose serves as a substrate for ATP production, providing cellular energy. Studies in animals and humans show that riboceine supplementation elevates glutathione levels, reduces oxidative stress markers, and may protect normal cells from chemotherapy-induced cytotoxicity by decreasing reactive oxygen species (ROS) and increasing intracellular glutathione[1][2][4][5][6][7][8]. The compound is primarily researched and commercialized for use as a dietary supplement to support antioxidant status, with potential benefits for aging, metabolic disorders, neuroprotection, and support during chemotherapy.
- Brand names
- RiboCeine
- Other names
- D-ribose-L-cysteineriboceine compoundRiboCeine™
02
Targets
GSS (Glutathione synthetase)GCL (Gamma-glutamylcysteine Synthetase)
Beyond the preview
Go deeper on riboceine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on riboceine.